Martina Hahn

556 total citations
42 papers, 339 citations indexed

About

Martina Hahn is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology. According to data from OpenAlex, Martina Hahn has authored 42 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 14 papers in Pediatrics, Perinatology and Child Health and 10 papers in Geriatrics and Gerontology. Recurrent topics in Martina Hahn's work include Pharmaceutical studies and practices (12 papers), Schizophrenia research and treatment (12 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Martina Hahn is often cited by papers focused on Pharmaceutical studies and practices (12 papers), Schizophrenia research and treatment (12 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Martina Hahn collaborates with scholars based in Germany, Switzerland and Austria. Martina Hahn's co-authors include Christoph Hiemke, Gudrun Hefner, A. Klimke, Sermin Toto, Jan Wolff, Dieter F. Braus, Günther Fischer, Fabio Ricciato, Julia Reiff and Daniel J. Müller and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Neurochemistry and Glia.

In The Last Decade

Martina Hahn

34 papers receiving 322 citations

Peers

Martina Hahn
Gudrun Hefner Germany
Elizabeth S. Duke United States
Serafina Chimirri Italy
Michele A. Faulkner United States
Per Hartvig Honoré Denmark
Marietta Anthony United States
Nahoko Kurosawa Japan
Julie Eve Desmarais Canada
Ingrid Castberg Norway
Paula Burger United States
Gudrun Hefner Germany
Martina Hahn
Citations per year, relative to Martina Hahn Martina Hahn (= 1×) peers Gudrun Hefner

Countries citing papers authored by Martina Hahn

Since Specialization
Citations

This map shows the geographic impact of Martina Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Hahn more than expected).

Fields of papers citing papers by Martina Hahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Hahn. The network helps show where Martina Hahn may publish in the future.

Co-authorship network of co-authors of Martina Hahn

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Hahn. A scholar is included among the top collaborators of Martina Hahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Hahn. Martina Hahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Scherf‐Clavel, Maike, et al.. (2025). Therapeutic Drug Monitoring of Cariprazine – Updated Values for a Dose-Related Reference Range. Pharmacopsychiatry. 58(3). 127–131. 1 indexed citations
3.
4.
Hahn, Martina, Simon S. Martin, Valentina O. Püntmann, et al.. (2024). When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis. CNS Drugs. 38(9). 671–696. 7 indexed citations
5.
6.
Scherf‐Clavel, Maike, Andreas Eckert, Heike Weber, et al.. (2023). Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study. International Journal of Clinical Pharmacy. 45(5). 1107–1117. 8 indexed citations
7.
Štuhec, Matej, et al.. (2023). Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health. International Journal of Clinical Pharmacy. 45(5). 1286–1292. 15 indexed citations
8.
Toto, Sermin, Gudrun Hefner, Martina Hahn, et al.. (2021). Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients. Journal of Neural Transmission. 128(2). 263–272. 9 indexed citations
9.
Hefner, Gudrun, Martina Hahn, Christoph Hiemke, et al.. (2021). Pharmacodynamic Drug–Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients. Journal of Neural Transmission. 128(2). 243–252. 16 indexed citations
10.
Hefner, Gudrun, Martina Hahn, Sermin Toto, et al.. (2020). Potentially inappropriate medication in older psychiatric patients. European Journal of Clinical Pharmacology. 77(3). 331–339. 20 indexed citations
11.
12.
Hahn, Martina, et al.. (2020). Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population. Pharmacopsychiatry. 54(2). 81–89. 14 indexed citations
13.
Hefner, Gudrun, et al.. (2018). Utility of duloxetine dose-related reference ranges calculated by AGNP consensus guidelines 2017. 1(1). 4–6. 1 indexed citations
14.
Hahn, Martina, et al.. (2017). Arzneimitteltherapiesicherheit an der stationär-ambulanten Schnittstelle. Der Nervenarzt. 89(7). 796–800. 2 indexed citations
15.
Hahn, Martina, et al.. (2016). Dosing Recommendations of Aripiprazole Depot with Strong Cytochrome P450 3A4 Inhibitors: A Relapse Risk. PubMed. 3(1). 5–5. 4 indexed citations
16.
Hahn, Martina, et al.. (2014). Das Pilotprojekt NetzWerkPlan©. PPH. 20(2). 86–90. 1 indexed citations
17.
Hahn, Martina, et al.. (2012). Towards a Eurostat framework for disseminating innovative/experimental statistics. Estadística española. 54(178). 197–210. 2 indexed citations
18.
Hahn, Martina & Dieter F. Braus. (2012). [Psychiatric polypharmacy: hazard through drug-drug-interaction and possibilities for prevention].. PubMed. 64(3). 127–31. 5 indexed citations
19.
Hahn, Martina, et al.. (1995). Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): Effects on intracellular calcium and platelet aggregation. Cardiovascular Drugs and Therapy. 9(6). 815–821. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gudrun Hefner Breakdown of academic impact, for papers by Elizabeth S. Duke Breakdown of academic impact, for papers by Serafina Chimirri Breakdown of academic impact, for papers by Michele A. Faulkner Breakdown of academic impact, for papers by Per Hartvig Honoré Breakdown of academic impact, for papers by Marietta Anthony Breakdown of academic impact, for papers by Nahoko Kurosawa Breakdown of academic impact, for papers by Julie Eve Desmarais Breakdown of academic impact, for papers by Ingrid Castberg Breakdown of academic impact, for papers by Paula Burger
Rankless by CCL
2026